Thermogenesis Holdings, Inc. (THMO): Price and Financial Metrics
THMO Price/Volume Stats
| Current price | $0.70 | 52-week high | $2.36 |
| Prev. close | $0.69 | 52-week low | $0.36 |
| Day low | $0.68 | Volume | 19,600 |
| Day high | $0.75 | Avg. volume | 71,832 |
| 50-day MA | $0.78 | Dividend yield | N/A |
| 200-day MA | $0.93 | Market Cap | 5.60M |
THMO Stock Price Chart Interactive Chart >
Thermogenesis Holdings, Inc. (THMO) Company Bio
Thermogenesis Holdings, Inc. serves customers in the United States.
Latest THMO News From Around the Web
Below are the latest news stories about THERMOGENESIS HOLDINGS INC that investors may wish to consider to help them evaluate THMO as an investment opportunity.
Shareholders Will Probably Hold Off On Increasing ThermoGenesis Holdings, Inc.'s (NASDAQ:THMO) CEO Compensation For The Time BeingKey Insights ThermoGenesis Holdings will host its Annual General Meeting on 14th of December Salary of US$519.0k is... |
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2023 Earnings Call TranscriptThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2023 Earnings Call Transcript November 13, 2023 Operator: Good day. And welcome to the ThermoGenesis Holdings Conference Call and Webcast to Review Financial and Operating Results for the Third Quarter ended September 30, 2023. As a reminder, this call is being recorded today. I would now like to turn the […] |
Q3 2023 Thermogenesis Holdings Inc Earnings CallQ3 2023 Thermogenesis Holdings Inc Earnings Call |
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the third quarter ended September 30, 2023, and provided a corporate business update. |
ThermoGenesis Holdings to Announce Financial Results for the Third Quarter Ended September 30, 2023, and Provide a Corporate Strategic UpdateThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the third quarter ended September 30, 2023, and provide a corporate strategic update on Thursday, November 13, 2023, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET. |
THMO Price Returns
| 1-mo | -11.08% |
| 3-mo | 32.08% |
| 6-mo | -33.33% |
| 1-year | -66.02% |
| 3-year | -99.41% |
| 5-year | -99.41% |
| YTD | 16.47% |
| 2023 | -81.22% |
| 2022 | -92.96% |
| 2021 | -51.67% |
| 2020 | -52.50% |
| 2019 | 64.79% |
Loading social stream, please wait...